Chemoinformaics analysis of 2-hydroxyrubiarbonone E
Molecular Weight | 486.693 | nRot | 2 |
Heavy Atom Molecular Weight | 440.325 | nRig | 27 |
Exact Molecular Weight | 486.335 | nRing | 5 |
Solubility: LogS | -4.597 | nHRing | 0 |
Solubility: LogP | 4.004 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 84.7825 |
nHD | 4 | BPOL | 47.0155 |
QED | 0.399 |
Synth | 5.44 |
Natural Product Likeliness | 3.077 |
NR-PPAR-gamma | 0.069 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.692 |
Pgp-sub | 0.001 |
HIA | 0.162 |
CACO-2 | -4.95 |
MDCK | 0.0000202 |
BBB | 0.97 |
PPB | 0.922156 |
VDSS | 0.61 |
FU | 0.0699542 |
CYP1A2-inh | 0.004 |
CYP1A2-sub | 0.466 |
CYP2c19-inh | 0.024 |
CYP2c19-sub | 0.9 |
CYP2c9-inh | 0.093 |
CYP2c9-sub | 0.109 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.099 |
CYP3a4-inh | 0.647 |
CYP3a4-sub | 0.532 |
CL | 16.031 |
T12 | 0.03 |
hERG | 0.002 |
Ames | 0.032 |
ROA | 0.842 |
SkinSen | 0.029 |
Carcinogencity | 0.217 |
EI | 0.019 |
Respiratory | 0.895 |
NR-Aromatase | 0.856 |
Antiviral | Yes |
Prediction | 0.700478 |